SSCA
ARKG icon

South Shore Capital Advisors’s ARK Genomic Revolution ETF ARKG Stock Holding History

South Shore Capital Advisors’s Portfolio ARKG Stock Details ARKG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-10,884
Closed -$965K – 98
2021
Q1 		$965K Buy
10,884
+8,317
+324% +$825K 0.96% 27
2020
Q4 		$239K Buy
+2,567
New +$205K 0.24% 106

Other funds holding ARKG

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SDH
Sloy Dahl & Holst Vancouver, Washington $728M AUM 37.66% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
EP
Eversept Partners New York $1.9B AUM 121.13% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

South Shore Capital Advisors's ARKG Position: Q2 2021 in Review

South Shore Capital Advisors sold out of ARK Genomic Revolution ETF (ARKG) in Q2 2021, closing a stake of 10,884 shares — an estimated $965K sold.

South Shore Capital Advisors first reported a position in ARKG in Q4 2020 and held it in 2 quarters. The position peaked at $965K in Q1 2021. 512 funds tracked by Wall St. Rank hold ARKG as of Q2 2021.

  • South Shore Capital Advisors reported no remaining ARK Genomic Revolution ETF position as of Q2 2021 after selling out during the quarter.
  • South Shore Capital Advisors sold 10,884 ARK Genomic Revolution ETF shares in Q2 2021, an estimated $965K.
  • South Shore Capital Advisors first reported a position in ARK Genomic Revolution ETF in Q4 2020 and held it in 2 quarters.
  • South Shore Capital Advisors's ARK Genomic Revolution ETF position peaked at $965K in Q1 2021.
  • 512 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2021.

Based on South Shore Capital Advisors's 13F filing for Q2 2021, filed 29 Jul 2021.